SteadyMed Ltd. (STDY) Updates on '393 Patent IPR; Remains Optimistic of Favorable Outcome
Tweet Send to a Friend
SteadyMed Ltd. (Nasdaq: STDY) provided an update regarding its ongoing Inter Partes Review (IPR), challenging U.S. Patent No. 8,497,393 (the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
